ARMK
Aramark
ARMK's fundamentals are mixed: free cash flow grew 54%, while its operating margin held steady at 4.4%. At 38x earnings, it's trading above its usual 33x. Analysts expect strong earnings growth.
ARMK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Weak |
ARMK's revenue and profitability are currently healthy, and its cash flow is stable, but its balance sheet is weak.
ARMK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $22.71 | -58% |
| Forward | 19x | $53.88 | — |
| Fair | 33x | $47.38 | -12% |
| Current | 38x | $53.88 | — |
| Expensive | 55x | $78.71 | +46% |
Historical ranges are pointers, not guarantees.
ARMK's PE is in its fair range at 38x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its cheap range.
ARMK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ARMK, with profitability holding steady.
ARMK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.81 | +96% |
| Q2 2026 | $1.43 | +5.9% |
| Q1 2026 | $1.34 | +3.1% |
| Q4 2025 | $1.19 | -6.3% |
| Q3 2025 | $1.22 | +23% |
| Q2 2025 | $1.35 | +2.3% |
| Q1 2025 | $1.30 | -46% |
| Q4 2024 | $1.27 | -47% |
| Q3 2024 | $0.99 | -61% |
ARMK's earnings per share have fallen from their peak: $1.43 over the past year, against $2.57 in late 2023.
ARMK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $5.1B | +9.3% |
| Q1 2026 | $4.9B | +15% |
| Q4 2025 | $4.8B | +6.1% |
| Q3 2025 | $5B | +14% |
| Q2 2025 | $4.6B | +5.7% |
| Q1 2025 | $4.3B | +1.9% |
| Q4 2024 | $4.6B | +3.3% |
| Q3 2024 | $4.4B | -9.9% |
ARMK's revenue has grown year over year for seven quarters in a row: $5.1B last quarter, up 9.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 4.3% | +0.3 points |
| Q1 2026 | 4.5% | +0.4 points |
| Q4 2025 | 4.5% | -0.3 points |
| Q3 2025 | 4.3% | -0.6 points |
| Q2 2025 | 4% | +0.3 points |
| Q1 2025 | 4.1% | +0.3 points |
| Q4 2024 | 4.8% | +1 points |
| Q3 2024 | 5% | -0.7 points |
ARMK's operating margin was 4.3% last quarter, about level with the same quarter a year ago.
ARMK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $4.8M | +$39.5M |
| Q1 2026 | $299M | +113% |
| Q4 2025 | -$904.4M | -$197.3M |
| Q3 2025 | $1B | +17% |
| Q2 2025 | -$34.7M | -162% |
| Q1 2025 | $140.1M | +4.7% |
| Q4 2024 | -$707M | +$65.7M |
| Q3 2024 | $882.3M | -0.5% |
ARMK generated $433M in free cash flow over the past year, up 54% from the year before.
ARMK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +2.1M shares |
| 1 year | +1.2% | +3.2M shares |
| 3 years | +2.2% | +5.8M shares |
| 5 years | +4.3% | +11.2M shares |
| Available history | +6.6% | +16.5M shares |
ARMK has 269M diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $913,000 |
| Q1 2026 | $25.1M |
| Q4 2025 | $41.3M |
| Q3 2025 | $29.7M |
| Q2 2025 | $30.9M |
| Q3 2021 | — |
| Q2 2021 | — |
| Q3 2020 | — |
ARMK spent $97M buying back its own shares over the past year.
ARMK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.1x | High |
| Q1 2026 | 4.2x | High |
| Q4 2025 | 4.5x | High |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 4.6x | High |
| Q1 2025 | 4.6x | High |
| Q4 2024 | 4.5x | High |
| Q3 2024 | 4.0x | High |
ARMK's net debt is about 4.0 years of its operating earnings (EBITDA), down from 4.6 years a year ago.
ARMK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.0 | Neutral |
| Stochastic | 23.6 | Neutral |
ARMK's weekly RSI is 51 (neutral) and its Stochastic is 24 (neutral).
ARMK PE vs Industrials Sector
| Metric | ARMK | Sector median | Relative |
|---|---|---|---|
| PE | 38x | 24x | 57% above |
| PE % | 55 | 58 | 3 pts below |
ARMK is trading at 38x earnings, a 57% premium to the Industrials sector's median of 24x.
ARMK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $54.2 | 0.6% below |
| 20 week MA | $56.3 | 4.4% below |
| 50 week MA | $48.6 | 11% above |
| 100 week MA | $43.4 | 24% above |
| 200 week MA | $37.2 | 45% above |
ARMK has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 45% above its 200-week average.
ARMK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.4 | $27.2 | -13% |
| 2021 | $27.2 | $26.0 | -4.2% |
| 2022 | $26.0 | $30.0 | +15% |
| 2023 | $30.0 | $28.1 | -6.2% |
| 2024 | $28.1 | $37.4 | +33% |
| 2025 | $37.4 | $37.4 | 0% |
| 2026 YTD | $37.4 | $53.9 | +44% |
ARMK is up 44% so far in 2026, after finishing lower in four of the previous six years.